Page last updated: 2024-11-13

hexenuronic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID102073560
MeSH IDM0250895

Synonyms (2)

Synonym
hexenuronic acid
YIUVUZOUGAOFMC-CAIVYNQRSA-N

Research Excerpts

Overview

Hexenuronic acid is a beta-elimination product of 4-O-methylglucuronic Acid. It is formed during kraft pulping.

ExcerptReferenceRelevance
"Hexenuronic acid is a beta-elimination product of 4-O-methylglucuronic acid and is formed during kraft pulping."( Characterisation of 4-deoxy-beta-L-threo-hex-4-enopyranosyluronic acid attached to xylan in pine kraft pulp and pulping liquor by 1H and 13C NMR spectroscopy.
Buchert, J; Drakenberg, T; Harjunpää, V; Hausalo, T; Teleman, A; Tenkanen, M; Vuorinen, T, 1995
)
1.01

Toxicity

ExcerptReferenceRelevance
" Moreover, the DKHA analog 6-(1-phenylmethyl-1H-indol-3-yl)-2,4-dioxo-5-hexenoic acid (RDS2119) was not toxic toward HeLa cells (CC(50) > 100 muM), whereas it showed significant cytotoxicity against the TDT(+) leukemia cell line MOLT-4 (CC(50) = 14."( Diketo hexenoic acid derivatives are novel selective non-nucleoside inhibitors of mammalian terminal deoxynucleotidyl transferases, with potent cytotoxic effect against leukemic cells.
Blanca, G; Costi, R; Crespan, E; Di Santo, R; Hübscher, U; Locatelli, GA; Maga, G; Roux, A; Shevelev, I; Spadari, S; Villani, G, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (13.64)18.2507
2000's5 (22.73)29.6817
2010's13 (59.09)24.3611
2020's1 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.99 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]